Antibodies that bind transforming growth factor beta (TGF beta) and methods of use thereof for treatment
US12071475B2 · kind B2 · utility
0Cited by
55References
19Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 15, 2021 |
| Grant date | Aug 27, 2024 |
| Priority date | — |
| Expiry date | Sep 20, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07K2317/92
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present disclosure relates, in general, to materials and methods for antibodies specific for transforming growth factor beta (TGFβ), including TGFβ1, TGFβ2 and TGFβ3, and uses of these antibodies in the treatment of subjects having cancer, an eye disease, condition or disorder, fibrosis, including ophthalmic fibrosis or fibrosis of the eye, and other conditions or disorders related to TGFβ expression.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.